Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

The refillable implant is surgically inserted into the eye during a one-time, outpatient procedure. The approval was based on positive one-year results from the phase 3 Pagoda study. In the trial, ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

In this Healio Video Perspective from Hawaiian Eye 2025, Richard Small, CEO of Neurotech Pharmaceuticals, discusses the ...

Retinitis pigmentosa is a relatively rare genetic disorder (affecting 1 in 3,500 people), while age-related macular degeneration affects 7–8% of the population, and its incidence increases with age.